12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSMUSG00000023852.7 | chromodomain helicase DNA binding protein 1 |
Pml
|
ENSMUSG00000036986.10 | promyelocytic leukemia |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Chd1 | mm10_v2_chr17_+_15704963_15704994 | -0.76 | 6.6e-03 | Click! |
Pml | mm10_v2_chr9_-_58249660_58249672 | -0.38 | 2.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_87625214 | 11.07 |
ENSMUST00000068088.6
|
Fam19a5
|
family with sequence similarity 19, member A5 |
chr12_-_84698769 | 8.82 |
ENSMUST00000095550.2
|
Syndig1l
|
synapse differentiation inducing 1 like |
chr11_-_119086221 | 6.54 |
ENSMUST00000026665.7
|
Cbx4
|
chromobox 4 |
chr9_+_114978507 | 6.31 |
ENSMUST00000183104.1
|
Osbpl10
|
oxysterol binding protein-like 10 |
chr13_-_71963713 | 5.82 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr11_+_120530688 | 5.78 |
ENSMUST00000026119.7
|
Gcgr
|
glucagon receptor |
chr4_+_137277489 | 5.65 |
ENSMUST00000045747.4
|
Wnt4
|
wingless-related MMTV integration site 4 |
chr5_+_138995038 | 4.99 |
ENSMUST00000100518.2
|
6330403L08Rik
|
RIKEN cDNA 6330403L08 gene |
chr6_+_107529717 | 4.75 |
ENSMUST00000049285.8
|
Lrrn1
|
leucine rich repeat protein 1, neuronal |
chr17_+_24752980 | 4.70 |
ENSMUST00000044922.6
|
Hs3st6
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 6 |
chr7_+_49974864 | 4.58 |
ENSMUST00000081872.5
ENSMUST00000151721.1 |
Nell1
|
NEL-like 1 |
chr18_+_74442500 | 4.43 |
ENSMUST00000074157.6
|
Myo5b
|
myosin VB |
chr6_-_145250177 | 4.30 |
ENSMUST00000111710.1
ENSMUST00000155145.1 ENSMUST00000032399.5 |
Kras
|
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
chr7_-_134938264 | 4.27 |
ENSMUST00000171394.1
|
Fam196a
|
family with sequence similarity 196, member A |
chrX_+_69360294 | 4.25 |
ENSMUST00000033532.6
|
Aff2
|
AF4/FMR2 family, member 2 |
chr11_+_61022560 | 4.24 |
ENSMUST00000089184.4
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr13_+_38151324 | 4.17 |
ENSMUST00000127906.1
|
Dsp
|
desmoplakin |
chr11_-_69122589 | 4.10 |
ENSMUST00000180487.1
|
9130213A22Rik
|
RIKEN cDNA 9130213A22 gene |
chr19_-_10457447 | 4.09 |
ENSMUST00000171400.2
|
Lrrc10b
|
leucine rich repeat containing 10B |
chr4_-_11386679 | 4.07 |
ENSMUST00000043781.7
ENSMUST00000108310.1 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr13_+_72628802 | 4.02 |
ENSMUST00000074372.4
|
Irx2
|
Iroquois related homeobox 2 (Drosophila) |
chr5_+_129941949 | 3.89 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr4_-_11386757 | 3.87 |
ENSMUST00000108313.1
ENSMUST00000108311.2 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr13_+_38151343 | 3.80 |
ENSMUST00000124830.1
|
Dsp
|
desmoplakin |
chr7_+_49975228 | 3.78 |
ENSMUST00000107603.1
|
Nell1
|
NEL-like 1 |
chr8_+_76899772 | 3.72 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr17_+_26113286 | 3.67 |
ENSMUST00000025010.7
|
Tmem8
|
transmembrane protein 8 (five membrane-spanning domains) |
chr1_+_167001417 | 3.63 |
ENSMUST00000165874.1
|
Fam78b
|
family with sequence similarity 78, member B |
chr1_-_134235420 | 3.61 |
ENSMUST00000038191.6
ENSMUST00000086465.4 |
Adora1
|
adenosine A1 receptor |
chr16_-_22163299 | 3.61 |
ENSMUST00000100052.4
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr5_+_141241490 | 3.59 |
ENSMUST00000085774.4
|
Sdk1
|
sidekick homolog 1 (chicken) |
chr8_+_84415348 | 3.57 |
ENSMUST00000121390.1
ENSMUST00000122053.1 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr10_+_82985473 | 3.56 |
ENSMUST00000040110.7
|
Chst11
|
carbohydrate sulfotransferase 11 |
chr4_+_138454305 | 3.53 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr13_+_48968287 | 3.53 |
ENSMUST00000180775.1
|
Fam120aos
|
family with sequence similarity 120A opposite strand |
chr18_+_74442551 | 3.52 |
ENSMUST00000121875.1
|
Myo5b
|
myosin VB |
chr2_-_153529941 | 3.52 |
ENSMUST00000035346.7
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr12_-_79007276 | 3.49 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr11_-_107794557 | 3.47 |
ENSMUST00000021066.3
|
Cacng4
|
calcium channel, voltage-dependent, gamma subunit 4 |
chr17_-_63499983 | 3.40 |
ENSMUST00000024761.6
|
Fbxl17
|
F-box and leucine-rich repeat protein 17 |
chr5_+_117357274 | 3.35 |
ENSMUST00000031309.9
|
Wsb2
|
WD repeat and SOCS box-containing 2 |
chr2_-_34372004 | 3.31 |
ENSMUST00000113132.2
ENSMUST00000040638.8 |
Pbx3
|
pre B cell leukemia homeobox 3 |
chr6_-_100287441 | 3.28 |
ENSMUST00000101118.2
|
Rybp
|
RING1 and YY1 binding protein |
chrX_+_142681398 | 3.26 |
ENSMUST00000112889.1
ENSMUST00000101198.2 ENSMUST00000112891.1 ENSMUST00000087333.2 |
Tmem164
|
transmembrane protein 164 |
chr5_-_138994935 | 3.20 |
ENSMUST00000046901.7
ENSMUST00000076095.7 |
Pdgfa
|
platelet derived growth factor, alpha |
chr17_+_69969217 | 3.20 |
ENSMUST00000060072.5
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr15_-_75747922 | 3.19 |
ENSMUST00000062002.4
|
Mafa
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
chr12_-_104865076 | 3.19 |
ENSMUST00000109937.1
ENSMUST00000109936.1 |
Clmn
|
calmin |
chr8_-_90348343 | 3.18 |
ENSMUST00000109621.3
|
Tox3
|
TOX high mobility group box family member 3 |
chr14_+_14703025 | 3.17 |
ENSMUST00000057015.6
|
Slc4a7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
chr4_-_118291340 | 3.15 |
ENSMUST00000049074.6
|
Ptprf
|
protein tyrosine phosphatase, receptor type, F |
chrX_-_162643575 | 3.13 |
ENSMUST00000101102.1
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chr2_+_130295148 | 3.12 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr7_+_121865070 | 2.99 |
ENSMUST00000033161.5
|
Scnn1b
|
sodium channel, nonvoltage-gated 1 beta |
chr11_-_72135721 | 2.99 |
ENSMUST00000108508.2
ENSMUST00000075258.6 |
Pitpnm3
|
PITPNM family member 3 |
chr2_+_157914618 | 2.98 |
ENSMUST00000109523.1
|
Vstm2l
|
V-set and transmembrane domain containing 2-like |
chr17_+_87635974 | 2.96 |
ENSMUST00000053577.8
|
Epcam
|
epithelial cell adhesion molecule |
chr16_+_64851991 | 2.93 |
ENSMUST00000067744.7
|
Cggbp1
|
CGG triplet repeat binding protein 1 |
chr11_-_89302545 | 2.88 |
ENSMUST00000061728.3
|
Nog
|
noggin |
chr5_-_136567242 | 2.86 |
ENSMUST00000175975.2
ENSMUST00000176216.2 ENSMUST00000176745.1 |
Cux1
|
cut-like homeobox 1 |
chr17_+_69969387 | 2.86 |
ENSMUST00000146730.1
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr9_+_107399858 | 2.86 |
ENSMUST00000085092.5
ENSMUST00000164988.2 |
Cacna2d2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
chr11_-_69369377 | 2.84 |
ENSMUST00000092971.6
ENSMUST00000108661.1 |
Chd3
|
chromodomain helicase DNA binding protein 3 |
chr8_-_90348126 | 2.78 |
ENSMUST00000176034.1
ENSMUST00000176616.1 |
Tox3
|
TOX high mobility group box family member 3 |
chrX_-_7574120 | 2.75 |
ENSMUST00000045924.7
ENSMUST00000115742.2 ENSMUST00000150787.1 |
Ppp1r3f
|
protein phosphatase 1, regulatory (inhibitor) subunit 3F |
chr1_+_167001457 | 2.75 |
ENSMUST00000126198.1
|
Fam78b
|
family with sequence similarity 78, member B |
chr15_+_98634743 | 2.74 |
ENSMUST00000003442.7
|
Cacnb3
|
calcium channel, voltage-dependent, beta 3 subunit |
chrX_+_161717055 | 2.73 |
ENSMUST00000112338.1
|
Rai2
|
retinoic acid induced 2 |
chrX_-_162888426 | 2.71 |
ENSMUST00000033723.3
|
Syap1
|
synapse associated protein 1 |
chr5_+_30588078 | 2.70 |
ENSMUST00000066295.2
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chr12_+_108792946 | 2.70 |
ENSMUST00000021692.7
|
Yy1
|
YY1 transcription factor |
chr16_-_24393588 | 2.69 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr19_+_3851972 | 2.67 |
ENSMUST00000025760.6
|
Chka
|
choline kinase alpha |
chr7_-_16614937 | 2.67 |
ENSMUST00000171937.1
ENSMUST00000075845.4 |
Grlf1
|
glucocorticoid receptor DNA binding factor 1 |
chr7_+_35334175 | 2.62 |
ENSMUST00000032705.6
ENSMUST00000085556.3 |
Rhpn2
|
rhophilin, Rho GTPase binding protein 2 |
chr5_-_106458440 | 2.61 |
ENSMUST00000086795.6
|
Barhl2
|
BarH-like 2 (Drosophila) |
chr11_+_104132841 | 2.59 |
ENSMUST00000093925.4
|
Crhr1
|
corticotropin releasing hormone receptor 1 |
chr15_+_89059712 | 2.59 |
ENSMUST00000161372.1
ENSMUST00000162424.1 |
Panx2
|
pannexin 2 |
chr13_-_43480973 | 2.58 |
ENSMUST00000144326.2
|
Ranbp9
|
RAN binding protein 9 |
chr14_-_29721835 | 2.58 |
ENSMUST00000022567.7
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr16_-_46496955 | 2.57 |
ENSMUST00000023335.6
ENSMUST00000023334.8 |
Pvrl3
|
poliovirus receptor-related 3 |
chr4_-_128806045 | 2.57 |
ENSMUST00000106072.2
ENSMUST00000170934.1 |
Zfp362
|
zinc finger protein 362 |
chr4_-_154299851 | 2.55 |
ENSMUST00000154895.1
|
Arhgef16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr13_-_92131494 | 2.55 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr4_-_3938354 | 2.53 |
ENSMUST00000003369.3
|
Plag1
|
pleiomorphic adenoma gene 1 |
chrX_-_162643629 | 2.52 |
ENSMUST00000112334.1
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chr3_+_114904062 | 2.52 |
ENSMUST00000081752.6
|
Olfm3
|
olfactomedin 3 |
chr5_-_138996087 | 2.51 |
ENSMUST00000110897.1
|
Pdgfa
|
platelet derived growth factor, alpha |
chr4_-_154300029 | 2.51 |
ENSMUST00000030898.5
|
Arhgef16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr7_-_46179929 | 2.49 |
ENSMUST00000033123.6
|
Abcc8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
chr10_+_79716588 | 2.49 |
ENSMUST00000099513.1
ENSMUST00000020581.2 |
Hcn2
|
hyperpolarization-activated, cyclic nucleotide-gated K+ 2 |
chrX_+_161717498 | 2.49 |
ENSMUST00000061514.7
|
Rai2
|
retinoic acid induced 2 |
chr12_-_4841583 | 2.49 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr1_-_9967932 | 2.49 |
ENSMUST00000185184.1
|
Tcf24
|
transcription factor 24 |
chr7_+_113207465 | 2.49 |
ENSMUST00000047321.7
|
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr3_-_90465858 | 2.48 |
ENSMUST00000029540.6
|
Npr1
|
natriuretic peptide receptor 1 |
chr12_-_24680890 | 2.47 |
ENSMUST00000156453.2
|
Cys1
|
cystin 1 |
chr9_-_96889381 | 2.45 |
ENSMUST00000112951.2
ENSMUST00000126411.1 ENSMUST00000078478.1 ENSMUST00000119141.1 ENSMUST00000120101.1 |
Acpl2
|
acid phosphatase-like 2 |
chr1_-_3671498 | 2.44 |
ENSMUST00000070533.4
|
Xkr4
|
X Kell blood group precursor related family member 4 |
chr9_+_109095427 | 2.44 |
ENSMUST00000072093.6
|
Plxnb1
|
plexin B1 |
chr4_+_62965560 | 2.43 |
ENSMUST00000030043.6
ENSMUST00000107415.1 ENSMUST00000064814.5 |
Zfp618
|
zinc finger protein 618 |
chr15_+_54571358 | 2.41 |
ENSMUST00000025356.2
|
Mal2
|
mal, T cell differentiation protein 2 |
chr9_+_100643755 | 2.41 |
ENSMUST00000133388.1
|
Stag1
|
stromal antigen 1 |
chrX_+_94724569 | 2.38 |
ENSMUST00000101388.2
|
Zxdb
|
zinc finger, X-linked, duplicated B |
chr5_-_143732273 | 2.38 |
ENSMUST00000053287.5
|
Usp42
|
ubiquitin specific peptidase 42 |
chr17_+_5841307 | 2.33 |
ENSMUST00000002436.9
|
Snx9
|
sorting nexin 9 |
chr2_+_90885860 | 2.32 |
ENSMUST00000111466.2
|
C1qtnf4
|
C1q and tumor necrosis factor related protein 4 |
chr4_+_3938904 | 2.31 |
ENSMUST00000120732.1
ENSMUST00000041122.4 ENSMUST00000121651.1 ENSMUST00000121210.1 ENSMUST00000119307.1 ENSMUST00000123769.1 |
Chchd7
|
coiled-coil-helix-coiled-coil-helix domain containing 7 |
chr5_-_100159261 | 2.30 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr2_+_78869009 | 2.28 |
ENSMUST00000028398.7
|
Ube2e3
|
ubiquitin-conjugating enzyme E2E 3 |
chr2_+_70562854 | 2.26 |
ENSMUST00000130998.1
|
Gad1
|
glutamate decarboxylase 1 |
chr5_-_122050102 | 2.26 |
ENSMUST00000154139.1
|
Cux2
|
cut-like homeobox 2 |
chr16_-_18586959 | 2.25 |
ENSMUST00000009241.5
|
Tbx1
|
T-box 1 |
chr5_+_125003440 | 2.23 |
ENSMUST00000036109.3
|
Fam101a
|
family with sequence similarity 101, member A |
chr6_-_118197732 | 2.22 |
ENSMUST00000032201.5
ENSMUST00000088790.3 |
Ret
|
ret proto-oncogene |
chrX_-_135009185 | 2.21 |
ENSMUST00000113185.2
ENSMUST00000064659.5 |
Zmat1
|
zinc finger, matrin type 1 |
chr6_-_122486252 | 2.20 |
ENSMUST00000068242.6
|
Rimklb
|
ribosomal modification protein rimK-like family member B |
chr4_-_70534904 | 2.20 |
ENSMUST00000107359.2
|
Megf9
|
multiple EGF-like-domains 9 |
chr9_-_77544829 | 2.20 |
ENSMUST00000183734.1
|
Lrrc1
|
leucine rich repeat containing 1 |
chr4_-_151996113 | 2.18 |
ENSMUST00000055688.9
|
Phf13
|
PHD finger protein 13 |
chr4_-_45530330 | 2.18 |
ENSMUST00000061986.5
|
Shb
|
src homology 2 domain-containing transforming protein B |
chr2_-_128967725 | 2.17 |
ENSMUST00000099385.2
|
Gm10762
|
predicted gene 10762 |
chr8_+_127064022 | 2.17 |
ENSMUST00000160272.1
ENSMUST00000079777.5 ENSMUST00000162907.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr8_-_94012558 | 2.17 |
ENSMUST00000053766.6
|
Amfr
|
autocrine motility factor receptor |
chr1_-_136234113 | 2.16 |
ENSMUST00000120339.1
ENSMUST00000048668.8 |
5730559C18Rik
|
RIKEN cDNA 5730559C18 gene |
chr1_+_36511867 | 2.16 |
ENSMUST00000001166.7
ENSMUST00000097776.3 |
Cnnm3
|
cyclin M3 |
chr3_+_40950631 | 2.15 |
ENSMUST00000048490.6
|
Larp1b
|
La ribonucleoprotein domain family, member 1B |
chr13_-_52981027 | 2.15 |
ENSMUST00000071065.7
|
Nfil3
|
nuclear factor, interleukin 3, regulated |
chr15_-_79804717 | 2.15 |
ENSMUST00000023057.8
|
Nptxr
|
neuronal pentraxin receptor |
chr16_+_18127607 | 2.15 |
ENSMUST00000059589.5
|
Rtn4r
|
reticulon 4 receptor |
chr17_+_8801742 | 2.13 |
ENSMUST00000089085.2
|
Pde10a
|
phosphodiesterase 10A |
chr4_-_114908892 | 2.13 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr2_+_58567360 | 2.13 |
ENSMUST00000071543.5
|
Upp2
|
uridine phosphorylase 2 |
chr5_+_73491026 | 2.11 |
ENSMUST00000063882.5
ENSMUST00000113558.1 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr11_+_45980309 | 2.11 |
ENSMUST00000049038.3
|
Sox30
|
SRY-box containing gene 30 |
chr8_+_40423786 | 2.11 |
ENSMUST00000049389.4
ENSMUST00000128166.1 ENSMUST00000167766.1 |
Zdhhc2
|
zinc finger, DHHC domain containing 2 |
chr13_-_48870885 | 2.10 |
ENSMUST00000035540.7
|
Phf2
|
PHD finger protein 2 |
chr5_-_52471534 | 2.10 |
ENSMUST00000059428.5
|
Ccdc149
|
coiled-coil domain containing 149 |
chr8_+_61224162 | 2.09 |
ENSMUST00000034060.5
|
Sh3rf1
|
SH3 domain containing ring finger 1 |
chr19_+_53677286 | 2.09 |
ENSMUST00000095969.3
ENSMUST00000164202.1 |
Rbm20
|
RNA binding motif protein 20 |
chr16_-_20621255 | 2.08 |
ENSMUST00000052939.2
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr12_+_44328882 | 2.07 |
ENSMUST00000020939.8
ENSMUST00000110748.2 |
Nrcam
|
neuron-glia-CAM-related cell adhesion molecule |
chr7_-_19796789 | 2.07 |
ENSMUST00000108449.2
ENSMUST00000043822.7 |
Cblc
|
Casitas B-lineage lymphoma c |
chr16_+_81200697 | 2.07 |
ENSMUST00000067602.3
ENSMUST00000037785.7 |
Ncam2
|
neural cell adhesion molecule 2 |
chr12_+_71016658 | 2.07 |
ENSMUST00000125125.1
|
Arid4a
|
AT rich interactive domain 4A (RBP1-like) |
chr11_+_3983704 | 2.06 |
ENSMUST00000063004.7
|
Gal3st1
|
galactose-3-O-sulfotransferase 1 |
chr8_-_70353243 | 2.06 |
ENSMUST00000075666.6
|
Upf1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
chr19_+_3851797 | 2.05 |
ENSMUST00000072055.6
|
Chka
|
choline kinase alpha |
chr17_+_65783355 | 2.04 |
ENSMUST00000073104.4
ENSMUST00000160664.1 ENSMUST00000162272.1 |
Ppp4r1
|
protein phosphatase 4, regulatory subunit 1 |
chr5_+_137288273 | 2.04 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr19_+_27217357 | 2.03 |
ENSMUST00000047645.6
ENSMUST00000167487.1 |
Vldlr
|
very low density lipoprotein receptor |
chr4_+_3938888 | 2.03 |
ENSMUST00000121110.1
ENSMUST00000108386.1 ENSMUST00000149544.1 |
Chchd7
|
coiled-coil-helix-coiled-coil-helix domain containing 7 |
chr10_-_83337440 | 2.03 |
ENSMUST00000126617.1
|
Slc41a2
|
solute carrier family 41, member 2 |
chr17_-_87282771 | 2.03 |
ENSMUST00000161759.1
|
4833418N02Rik
|
RIKEN cDNA 4833418N02 gene |
chr6_+_86526271 | 2.02 |
ENSMUST00000180896.1
|
1600020E01Rik
|
RIKEN cDNA 1600020E01 gene |
chr17_-_24533709 | 2.02 |
ENSMUST00000061764.7
|
Rab26
|
RAB26, member RAS oncogene family |
chr8_+_127064107 | 2.02 |
ENSMUST00000162536.1
ENSMUST00000026921.6 ENSMUST00000162665.1 ENSMUST00000160766.1 ENSMUST00000162602.1 ENSMUST00000162531.1 ENSMUST00000160581.1 ENSMUST00000161355.1 ENSMUST00000159537.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr4_-_93335510 | 2.01 |
ENSMUST00000066774.4
|
Tusc1
|
tumor suppressor candidate 1 |
chr10_-_71159676 | 2.01 |
ENSMUST00000014473.5
ENSMUST00000143791.1 |
Bicc1
|
bicaudal C homolog 1 (Drosophila) |
chr9_+_107400043 | 2.01 |
ENSMUST00000166799.1
ENSMUST00000170737.1 |
Cacna2d2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
chr2_-_144011202 | 2.01 |
ENSMUST00000016072.5
ENSMUST00000037875.5 |
Rrbp1
|
ribosome binding protein 1 |
chr5_-_36484112 | 2.01 |
ENSMUST00000119916.1
ENSMUST00000031097.7 |
Tada2b
|
transcriptional adaptor 2B |
chr11_+_114851814 | 2.00 |
ENSMUST00000053361.5
ENSMUST00000021071.7 ENSMUST00000136785.1 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr16_-_46496772 | 2.00 |
ENSMUST00000149901.1
ENSMUST00000096052.2 |
Pvrl3
|
poliovirus receptor-related 3 |
chr4_-_139092958 | 2.00 |
ENSMUST00000042844.6
|
Nbl1
|
neuroblastoma, suppression of tumorigenicity 1 |
chr15_-_75566811 | 2.00 |
ENSMUST00000065417.8
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr12_+_112678803 | 1.99 |
ENSMUST00000174780.1
ENSMUST00000169593.1 ENSMUST00000173942.1 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr17_+_24696234 | 1.98 |
ENSMUST00000019464.7
|
Noxo1
|
NADPH oxidase organizer 1 |
chr11_+_68556186 | 1.98 |
ENSMUST00000053211.6
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr1_+_132880273 | 1.98 |
ENSMUST00000027706.3
|
Lrrn2
|
leucine rich repeat protein 2, neuronal |
chr17_-_25256274 | 1.98 |
ENSMUST00000182435.1
ENSMUST00000169109.2 ENSMUST00000182056.1 |
Baiap3
|
BAI1-associated protein 3 |
chr11_-_102296618 | 1.96 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr4_-_126533472 | 1.96 |
ENSMUST00000084289.4
|
Ago4
|
argonaute RISC catalytic subunit 4 |
chr15_-_78120011 | 1.95 |
ENSMUST00000019290.2
|
Cacng2
|
calcium channel, voltage-dependent, gamma subunit 2 |
chr4_+_33924632 | 1.95 |
ENSMUST00000057188.6
|
Cnr1
|
cannabinoid receptor 1 (brain) |
chr4_+_54947976 | 1.95 |
ENSMUST00000098070.3
|
Zfp462
|
zinc finger protein 462 |
chr17_-_27204357 | 1.94 |
ENSMUST00000055117.7
|
Lemd2
|
LEM domain containing 2 |
chr7_+_81213567 | 1.93 |
ENSMUST00000026672.7
|
Pde8a
|
phosphodiesterase 8A |
chr6_-_124769548 | 1.93 |
ENSMUST00000149652.1
ENSMUST00000112476.1 ENSMUST00000004378.8 |
Eno2
|
enolase 2, gamma neuronal |
chr7_-_66427469 | 1.92 |
ENSMUST00000015278.7
|
Aldh1a3
|
aldehyde dehydrogenase family 1, subfamily A3 |
chr3_-_122619442 | 1.91 |
ENSMUST00000162947.1
|
Fnbp1l
|
formin binding protein 1-like |
chr9_+_103112072 | 1.91 |
ENSMUST00000035155.6
|
Rab6b
|
RAB6B, member RAS oncogene family |
chr5_+_36484578 | 1.90 |
ENSMUST00000060100.1
|
Ccdc96
|
coiled-coil domain containing 96 |
chr3_-_57847478 | 1.89 |
ENSMUST00000120289.1
ENSMUST00000066882.8 |
Pfn2
|
profilin 2 |
chr3_-_84480419 | 1.89 |
ENSMUST00000107689.1
|
Fhdc1
|
FH2 domain containing 1 |
chr15_-_32244632 | 1.88 |
ENSMUST00000181536.1
|
0610007N19Rik
|
RIKEN cDNA 0610007N19 |
chr17_+_69969073 | 1.88 |
ENSMUST00000133983.1
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr4_-_11386394 | 1.87 |
ENSMUST00000155519.1
|
Esrp1
|
epithelial splicing regulatory protein 1 |
chrX_-_20291728 | 1.87 |
ENSMUST00000115393.2
|
Slc9a7
|
solute carrier family 9 (sodium/hydrogen exchanger), member 7 |
chr19_+_6341121 | 1.86 |
ENSMUST00000025897.6
ENSMUST00000130382.1 |
Map4k2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr4_-_155222535 | 1.85 |
ENSMUST00000084103.3
ENSMUST00000030917.5 |
Ski
|
ski sarcoma viral oncogene homolog (avian) |
chr9_-_40964118 | 1.85 |
ENSMUST00000034521.7
|
4931429I11Rik
|
RIKEN cDNA 4931429I11 gene |
chr7_+_19094594 | 1.84 |
ENSMUST00000049454.5
|
Six5
|
sine oculis-related homeobox 5 |
chr6_+_29396665 | 1.84 |
ENSMUST00000096084.5
|
Ccdc136
|
coiled-coil domain containing 136 |
chr19_-_47464406 | 1.84 |
ENSMUST00000111800.2
ENSMUST00000081619.2 |
Sh3pxd2a
|
SH3 and PX domains 2A |
chr2_-_90580578 | 1.84 |
ENSMUST00000168621.2
|
Ptprj
|
protein tyrosine phosphatase, receptor type, J |
chr17_-_87282793 | 1.83 |
ENSMUST00000146560.2
|
4833418N02Rik
|
RIKEN cDNA 4833418N02 gene |
chr13_-_34345174 | 1.82 |
ENSMUST00000040336.5
|
Slc22a23
|
solute carrier family 22, member 23 |
chr5_+_34369909 | 1.82 |
ENSMUST00000180376.1
|
Fam193a
|
family with sequence similarity 193, member A |
chr11_+_117115195 | 1.81 |
ENSMUST00000103026.3
ENSMUST00000090433.5 |
Sec14l1
|
SEC14-like 1 (S. cerevisiae) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 11.0 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
2.1 | 6.4 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
2.0 | 5.9 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
1.9 | 5.7 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
1.4 | 10.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.4 | 1.4 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.4 | 8.2 | GO:0032439 | endosome localization(GO:0032439) |
1.3 | 4.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
1.3 | 3.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.2 | 4.9 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
1.2 | 3.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.1 | 3.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.1 | 3.3 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.1 | 3.3 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
1.1 | 6.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.0 | 6.8 | GO:0019695 | choline metabolic process(GO:0019695) |
1.0 | 2.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 2.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.9 | 2.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.9 | 2.7 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.9 | 5.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.9 | 2.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.9 | 4.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 4.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.8 | 2.5 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.8 | 5.0 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 9.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.8 | 2.5 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.8 | 5.7 | GO:0051775 | response to redox state(GO:0051775) |
0.8 | 2.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.8 | 5.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.8 | 3.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 3.7 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.7 | 2.2 | GO:2001074 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.7 | 3.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 3.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.7 | 3.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 2.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 0.7 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
0.7 | 1.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.7 | 2.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 2.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 5.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.7 | 5.3 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 2.0 | GO:0048338 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.6 | 2.6 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.6 | 1.9 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.6 | 4.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 1.9 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.6 | 1.9 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.6 | 1.2 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.6 | 2.4 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.6 | 3.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.6 | 2.3 | GO:2000382 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
0.6 | 4.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.6 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.6 | 2.9 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 6.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 3.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.6 | 1.7 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.6 | 1.7 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.6 | 1.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.6 | 1.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 3.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 1.6 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.5 | 1.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.5 | 4.9 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.5 | 1.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.5 | 2.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.5 | 3.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 3.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.5 | 2.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 2.1 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.5 | 1.0 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.5 | 6.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 7.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 2.0 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 1.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 4.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.5 | 4.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.5 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 4.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 2.0 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 2.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.5 | 3.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 4.8 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) |
0.5 | 2.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 2.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.5 | 3.8 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.5 | 1.4 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.5 | 1.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 2.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 1.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 0.9 | GO:0051794 | regulation of catagen(GO:0051794) |
0.5 | 0.9 | GO:2000847 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 4.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.5 | 0.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.5 | 4.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 0.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 2.7 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.4 | 0.9 | GO:0038001 | paracrine signaling(GO:0038001) |
0.4 | 3.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 1.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 2.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 0.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.4 | 1.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.4 | 2.5 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.4 | 1.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 1.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 2.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 1.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.4 | 3.8 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 0.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 0.4 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 1.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 2.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 2.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 3.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 3.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.4 | 1.2 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.4 | 1.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 0.4 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.4 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 2.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 2.7 | GO:0015675 | nickel cation transport(GO:0015675) |
0.4 | 3.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 2.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.4 | 0.8 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 3.0 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.4 | 0.8 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.4 | 2.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.4 | 1.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.4 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 1.8 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 1.5 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.4 | 1.1 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.4 | 1.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 1.5 | GO:2000256 | thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
0.4 | 1.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.4 | 3.6 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 0.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.4 | 12.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.4 | 1.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.4 | 1.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 1.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 0.3 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.3 | 0.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.3 | 1.0 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.3 | 1.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 2.4 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.3 | 2.1 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.3 | 1.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 2.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 0.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 2.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 0.3 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.3 | 1.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.3 | 1.0 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.3 | 1.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 1.3 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.3 | 1.9 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.3 | 0.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 1.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 1.9 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 6.7 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 1.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 1.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 0.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.3 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 1.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.3 | 1.8 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 3.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 0.3 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
0.3 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 1.8 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.3 | 1.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 1.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 1.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.3 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.3 | 0.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 0.9 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.3 | 0.6 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.3 | 1.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 3.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 1.1 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.3 | 0.9 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.3 | 0.3 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.3 | 1.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 0.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 1.4 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.3 | 3.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 1.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 0.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.3 | 0.3 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.3 | 0.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 1.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.3 | 0.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 3.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 0.8 | GO:0007314 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.3 | 8.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 1.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 0.8 | GO:0015866 | ADP transport(GO:0015866) |
0.3 | 10.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 0.8 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.3 | 2.1 | GO:0060214 | endocardium formation(GO:0060214) |
0.3 | 0.3 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
0.3 | 2.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 1.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 0.8 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
0.3 | 1.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 1.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 2.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 4.2 | GO:0030238 | male sex determination(GO:0030238) |
0.3 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 0.8 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.3 | 0.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 1.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.3 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.3 | 0.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 4.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.3 | 1.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 9.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.7 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 1.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.5 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.2 | 0.7 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.2 | 1.0 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.2 | 1.2 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.2 | 0.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.5 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 1.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.7 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.2 | 0.7 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 2.4 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.2 | 1.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.5 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.2 | 0.7 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.2 | 2.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.7 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 1.2 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.2 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 1.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 1.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 4.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.2 | 1.2 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.2 | 1.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 2.3 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.2 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.4 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.2 | 0.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 1.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.7 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 1.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 2.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.9 | GO:0010286 | heat acclimation(GO:0010286) |
0.2 | 1.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 2.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 3.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 2.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 2.4 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 0.2 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.2 | 0.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.2 | GO:2000451 | positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
0.2 | 0.7 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 2.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 2.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.6 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 1.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.2 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 1.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.2 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.6 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
0.2 | 1.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.6 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 0.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 1.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.2 | 2.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 1.0 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.2 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 0.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 2.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 0.4 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.2 | 0.6 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 2.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 4.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 2.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.6 | GO:2000642 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.2 | 0.8 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 3.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 0.8 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.2 | 0.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 1.2 | GO:0071543 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.2 | 0.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.2 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.2 | 0.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.2 | 1.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 2.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.4 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.2 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.2 | 3.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.2 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 4.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 1.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) |
0.2 | 1.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 1.6 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.9 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 1.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 1.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.2 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.2 | 0.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 1.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 1.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 1.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.2 | 0.3 | GO:0060592 | mammary gland formation(GO:0060592) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.7 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 0.7 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.2 | 0.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.2 | 0.2 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.2 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 4.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 2.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 1.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 1.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.5 | GO:1990743 | protein sialylation(GO:1990743) |
0.2 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.2 | 1.2 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.2 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 0.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.5 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 1.3 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 0.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 1.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.6 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 0.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 | 1.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 1.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.5 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 5.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.5 | GO:0002606 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 0.5 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.2 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 2.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.2 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 1.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.5 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 0.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 2.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.9 | GO:0001787 | natural killer cell proliferation(GO:0001787) NK T cell proliferation(GO:0001866) |
0.1 | 0.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.4 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 1.3 | GO:0090110 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.6 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 1.1 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 2.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 5.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.6 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 2.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.1 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 1.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.8 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 2.5 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.3 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 1.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.9 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.1 | 0.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 3.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.9 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.4 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.3 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 1.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.1 | 1.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 1.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.5 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 0.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 2.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 6.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.5 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.1 | 5.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 1.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 2.7 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 3.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 1.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.5 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.1 | 1.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 1.2 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.1 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 3.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.5 | GO:0060003 | copper ion export(GO:0060003) |
0.1 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.5 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 4.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.1 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) regulation of endosome size(GO:0051036) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.3 | GO:0035546 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.1 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 2.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 3.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.1 | GO:0060220 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) camera-type eye photoreceptor cell fate commitment(GO:0060220) |
0.1 | 0.3 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.1 | 0.8 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 1.1 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.1 | 1.5 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0098705 | plasma membrane copper ion transport(GO:0015679) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 3.0 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.2 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 1.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.3 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.4 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.0 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.3 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 0.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.1 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.1 | 0.2 | GO:0035938 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.1 | 0.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 1.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.2 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.4 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.1 | 2.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 1.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 2.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.3 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.3 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 2.9 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.1 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 1.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.7 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.1 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.5 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.3 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.1 | 1.4 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.3 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 1.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.1 | 0.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.6 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.3 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 2.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.7 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 1.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 1.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.1 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.1 | 0.2 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.2 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.1 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 4.7 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 1.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.6 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 1.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.8 | GO:1901621 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 1.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.9 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0019085 | early viral transcription(GO:0019085) late viral transcription(GO:0019086) |
0.1 | 5.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 1.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.3 | GO:0090095 | re-entry into mitotic cell cycle(GO:0000320) canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.1 | 0.6 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 1.4 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 0.1 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.1 | 0.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:1901738 | regulation of isoprenoid metabolic process(GO:0019747) regulation of vitamin A metabolic process(GO:1901738) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.3 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.8 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 1.2 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.3 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.9 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.5 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.1 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.1 | 0.1 | GO:1900141 | oligodendrocyte apoptotic process(GO:0097252) regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) |
0.1 | 0.3 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.1 | 0.4 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.2 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.3 | GO:0046520 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.4 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 3.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 1.2 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 1.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.5 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 4.2 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.1 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 0.4 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.0 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.2 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 2.8 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.0 | 0.7 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.0 | 0.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.1 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.0 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.0 | 0.2 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.8 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.6 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.0 | 0.1 | GO:0060298 | sarcomerogenesis(GO:0048769) positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.0 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.0 | 0.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 1.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.0 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 1.6 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.0 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.1 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.4 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.5 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.1 | GO:0031179 | peptide modification(GO:0031179) |
0.0 | 1.4 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.2 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.3 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 0.0 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.0 | 1.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.1 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.0 | 0.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.3 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.0 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.7 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 1.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 2.2 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.0 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.3 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.0 | 0.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.4 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.0 | GO:0060502 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) epithelial cell proliferation involved in lung morphogenesis(GO:0060502) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.2 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.6 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0006788 | heme oxidation(GO:0006788) |
0.0 | 0.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.5 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.0 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.1 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.2 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.1 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.3 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) |
0.0 | 0.2 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.3 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.0 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.4 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.0 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.5 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.0 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.1 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.1 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.9 | 4.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.9 | 2.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.8 | 2.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.8 | 2.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 5.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 9.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 2.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.6 | 8.6 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 4.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 2.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 2.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.5 | 9.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 4.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 1.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.4 | 3.1 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 1.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.4 | 2.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 2.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 2.7 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 3.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 1.1 | GO:0036019 | endolysosome(GO:0036019) |
0.4 | 1.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 3.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 1.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 3.0 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.3 | 3.9 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 1.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 3.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 12.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 14.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 1.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 1.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 1.4 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 0.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 0.8 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.3 | 6.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 1.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 1.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.3 | 3.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 4.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 1.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 3.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.7 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 2.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 5.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 6.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.0 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 1.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 3.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 1.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 3.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 3.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 3.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 0.5 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.2 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 7.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.2 | 3.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.6 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 2.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 3.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 3.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 3.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 6.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 3.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 1.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.4 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 3.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.5 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 3.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 3.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.7 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 1.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 1.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 3.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 1.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 3.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 4.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 1.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.4 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 3.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 3.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 1.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 3.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.5 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 3.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.1 | 1.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.7 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.2 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.1 | 4.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 7.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 2.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.1 | GO:0005713 | recombination nodule(GO:0005713) |
0.1 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 2.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 3.4 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.1 | GO:0071914 | prominosome(GO:0071914) |
0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 0.2 | GO:0070110 | oncostatin-M receptor complex(GO:0005900) ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.2 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.2 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 2.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 5.0 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 8.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.2 | GO:0048500 | signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 2.7 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 2.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 2.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.5 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 4.3 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 57.0 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 4.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 2.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.6 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.7 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 26.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0044301 | climbing fiber(GO:0044301) |
0.0 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 2.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 2.9 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0019002 | GMP binding(GO:0019002) |
1.9 | 5.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.7 | 6.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.6 | 4.9 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.4 | 7.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.3 | 4.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.2 | 3.6 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
1.1 | 3.2 | GO:0005118 | sevenless binding(GO:0005118) |
0.9 | 2.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 6.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 2.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.9 | 3.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.9 | 2.6 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.9 | 2.6 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.7 | 2.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.7 | 4.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 12.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.7 | 2.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 2.6 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.6 | 2.6 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.6 | 3.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 1.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.6 | 4.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 2.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.6 | 4.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 2.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.6 | 4.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.6 | 3.9 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.6 | 2.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 1.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 1.7 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 1.6 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.5 | 3.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.5 | 6.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 2.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 2.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 2.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 1.4 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.5 | 3.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 2.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.5 | 4.2 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 2.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.5 | 1.4 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
0.5 | 3.6 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.4 | 4.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.7 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 3.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 3.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 3.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 1.3 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.4 | 2.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.4 | 0.8 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.4 | 2.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 2.7 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.4 | 2.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.4 | 4.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.4 | 2.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 3.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 1.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 3.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 2.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.4 | 2.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 1.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.4 | 5.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 1.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.4 | 1.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 1.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.3 | 1.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 1.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.3 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 6.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 0.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 1.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.3 | 1.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 1.3 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.3 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 4.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 2.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 3.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 1.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 3.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.1 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.3 | 3.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 7.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 1.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 0.8 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.3 | 1.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.3 | 1.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 3.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 6.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 2.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 2.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 13.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 3.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 21.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.2 | 5.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 0.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 1.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 2.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 2.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 2.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 3.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 3.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 3.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 3.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 3.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.1 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 1.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 1.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 2.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 2.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 4.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 1.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 8.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.0 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 1.2 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 1.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 2.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 3.4 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 2.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 2.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 0.4 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.2 | 1.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 1.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 2.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.5 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.2 | 0.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.2 | 1.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 2.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.7 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.2 | 0.5 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.2 | 0.5 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 1.7 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.2 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.5 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 2.1 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 6.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 2.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 6.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.1 | GO:0030977 | taurine binding(GO:0030977) |
0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 5.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.1 | 6.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 4.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 1.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.4 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 7.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 2.1 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.8 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 3.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.5 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.5 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.1 | 5.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 2.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.4 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 4.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 2.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.1 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.5 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.1 | 3.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 2.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 4.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.5 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.3 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.1 | 1.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 5.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 4.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 8.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.5 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 1.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 2.6 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 2.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 2.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 2.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.3 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 3.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 2.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 0.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.8 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.3 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.1 | 4.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.4 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 9.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 0.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.6 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.2 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.1 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.3 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.1 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 4.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.0 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 1.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 2.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 30.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 3.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.1 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.0 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 3.5 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:1902121 | bile acid binding(GO:0032052) lithocholic acid binding(GO:1902121) |
0.0 | 0.3 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 2.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 2.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.0 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 1.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.0 | 1.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 1.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.7 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.0 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 1.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 1.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.9 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 3.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 1.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0051381 | histamine binding(GO:0051381) |
0.0 | 0.0 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 2.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 14.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 6.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 5.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 19.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 3.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 10.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 10.3 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 1.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 4.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 3.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 3.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 5.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 4.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 3.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 8.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 3.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 13.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 7.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 2.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 5.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 3.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 5.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 3.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 2.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 2.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.5 | 8.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.5 | 9.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 6.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 3.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 5.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 7.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 12.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 4.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 8.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 2.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 8.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 4.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 8.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 3.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 11.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 10.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 6.4 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.2 | 4.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 2.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 5.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 6.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 5.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 5.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 8.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 2.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 4.8 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 2.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 5.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 2.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 2.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.3 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.1 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 4.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 6.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 3.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 3.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 5.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 4.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 7.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 2.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 7.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.3 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 4.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 7.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 4.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 14.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 4.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 3.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 3.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 3.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 2.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 1.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 3.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.0 | 0.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |